DisclosureWe earn commission on partner links; ranking is set by our published methodology — not advertisers.
An independent editorial review site for GLP‑1 medications. We review, score, and compare drugs and telehealth providers. We do not sell, prescribe, or dispense anything.
LoseLab is an editorially independent review publication covering GLP-1 weight-loss and diabetes medications, the telehealth providers that prescribe them, and the insurance and pricing landscape around them. Every clinical claim is verified against FDA labeling and peer-reviewed trials, with sources cited inline. We earn referral commission on outbound links, disclosed in full at our how-we-make-money page. We never sell or dispense medication.
Editorial scoring happens before any affiliate relationship is considered. When an unmonetized provider outscores a paying partner, the unmonetized provider ranks higher and we link it anyway. The clinician and editor who score a provider are not shown its payout rate. Negative findings on paying partners are published, including our provider legal-risk tracker.
Corrections, source questions, and press inquiries: [email protected]. We respond to documented factual corrections within five business days and date every correction we make.
LoseLab publishes editorial summaries, not medical advice. Always consult a licensed clinician for treatment decisions.